Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)
Clinical trial NCT00948389 · TERMINATED
Trial details
- NCT number
- NCT00948389
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-05-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.